{"id":"W2026116536","doi":"10.1056/nejmoa030815","title":"Infliximab Maintenance Therapy for Fistulizing Crohn's Disease","year":2004,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2221,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal General Hospital; University of Alberta; Vancouver General Hospital; Health Sciences Centre; Western University; University of Manitoba","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Infliximab; Maintenance therapy; Crohn's disease; Placebo; Surgery; Randomization; Internal medicine; Randomized controlled trial; Gastroenterology; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01134458852969855,"score_gpt":0.2630441158727721,"score_spread":0.2516995273430735,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}